Madhusudan Grover MD

Anorectal Function & Pelvic Floor Dysfunction, Gastrointestinal Functional & Motility Disorders

Consultant

200 1st St SWRochester, MN 55905
Phone+1 507-284-2511

Dr. Grover is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Grover's full profile Already have an account?

Education & Training

Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Gastroenterology, 2009 - 2012
University of Michigan Health - Sparrow/Michigan State UniversityResidency, Internal Medicine, 2006 - 2009
Maulana Azad Medical CollegeClass of 2005

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

MN State Medical License 2009 - 2027
AZ State Medical License 2022 - 2026
MI State Medical License 2006 - 2009
NC State Medical License 2008 - 2008
American Board of Internal Medicine Gastroenterology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 2 Certification Centricity Enterprise (CE), GE Healthcare, 2014-2017
CMS Meaningful Use Stage 1 Certification Centricity Patient Online, GE Healthcare, 2014-2017
CMS Meaningful Use Stage 1 Certification Centricity Enterprise, GE Healthcare, 2014-2017

Clinical Trials

Biomarkers for Intestinal Permeability in Patients With Constipation
COMPLETED
Gut Permeability, Sensitivity and Symptomatology Start of enrollment: 2015 Feb 01
Completed
Not Applicable
Epidemiology and Pathophysiology of Post-Infectious Functional GI Disorders
COMPLETED

Publications & Presentations

PubMed

Barrier restoration as a therapeutic strategy for disorders of gut-brain interaction.
Timmie A Britton, Madhusudan Grover
The Lancet. Gastroenterology & Hepatology. 2026-10-01
Maladaptive Piezo1 Mechanotransduction Drives Smooth Muscle Aging in the Gut.
Vikram Joshi, Corey Seavey, Kaitlyn Knutson, Abhilash Sawant, Yasmeen M F Hamed
Biorxiv. 2026-09-07
Abdominal Pain Sensitization Connected With Upper but Not Lower Abdominal Pain in Adults With Gastroparesis.
Helen Burton-Murray, Emily P Mitchell, Laura A Miriel, Henry P Parkman, Irene Sarosiek
Neurogastroenterology and Motility. 2026-09-01

Journal Articles

Psychological, Physical, and Sleep Comorbidities and Functional Impairment in Irritable Bowel Syndrome: Results from a National Survey of U.S. Adults
Madhusudan Grover, MD, PLoS One
Transcriptomic Signatures Reveal Immune Dysregulation in Human Diabetic and Idiopathic Gastroparesis
Pankaj J. Pasricha, Henry P. Parkman, Frank A. Hamilton, Robert J. Shulman, James Tonascia, Madhusudan Grover, Braden Kuo, Travis J. McKenzie, Michael L. Kendrick, BioMed Central

Authored Content

DDW 2022: A Blockbuster for Science and NetworkingMay 2022

Press Mentions

Microbiome Highlights from Digestive Disease Week 2025September 8th, 2025
Madhusudan Grover on Distinct Irritable Bowel Syndrome Patient SubsetsOctober 10th, 2022
Be Prepared for Long Covid IBSAugust 9th, 2022

Grant Support

Efficacy and Safety of Proteolytic Activity-Guided fecal Microbiota Transplantation for Irritable Bowel Syndrome (PRAGMAT trial)MAYO CLINIC ROCHESTER2024–2027
Microbiota based mechanisms of post-infection irritable bowel syndromeMAYO CLINIC ROCHESTER2021–2026
Microbiota based mechanisms of post-infection irritable bowel syndromeMAYO CLINIC ROCHESTER2021–2026
Pathophysiology of Diabetic GastroparesisMAYO CLINIC ROCHESTER2021–2025